VIZR TECHNOLOGY OÜ – Trademark Portfolio
Entity Type: 99
VIZR TECHNOLOGY OÜ holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include VIZR, NEUHEAD, and NEUROVIZR. The owner is based in TALLINN.
HARJU MAAKOND, HAABERSTI LINNAOSA
MEISTRI TN 16-204
TALLINN 13517 , EE
Showing of trademarks Trademarks
Trademark Classifications
VIZR TECHNOLOGY OÜ's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does VIZR TECHNOLOGY OÜ have?
VIZR TECHNOLOGY OÜ has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does VIZR TECHNOLOGY OÜ file in?
VIZR TECHNOLOGY OÜ files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 9 (Computers & Electronics), Class 11 (Environmental Control). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are VIZR TECHNOLOGY OÜ's most well-known trademarks?
VIZR TECHNOLOGY OÜ's registered trademark portfolio includes well-known marks such as VIZR, NEUHEAD, and NEUROVIZR. These are among 3 currently registered trademarks in the portfolio.
What is VIZR TECHNOLOGY OÜ's trademark registration success rate?
VIZR TECHNOLOGY OÜ has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.